Jun 12, 2025
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting
Apr 17, 2025
CalciMedica Announces Presentations at Upcoming Medical Meetings
Feb 19, 2025
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference
Nov 21, 2024
CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 13, 2024
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
Nov 07, 2024
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
Oct 30, 2024
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
Oct 28, 2024
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP)
Sep 03, 2024
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Jul 09, 2024
CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora(TM) in Severe Acute Kidney Injury (AKI)
Jul 08, 2024
CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences
Jul 01, 2024
CalciMedica Set to Join Russell Microcap® Index
Jun 27, 2024
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP)
May 13, 2024
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
May 07, 2024
CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024
May 07, 2024
CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024
Mar 28, 2024
CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
Feb 13, 2024
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora(TM) for the Treatment of Severe Acute Kidney Injury
Feb 07, 2024
CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Jan 22, 2024
CalciMedica Announces Private Placement of up to Approximately $55 Million